Noncoronary Sinus Pivot Implantation (NCPI) Strategy for Transcatheter Aortic Valve Replacement With Self‐Expanding Valve in Pure Native Aortic Regurgitation: A Multicenter, Registry Study From the CCA Database‐NTCVR
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70183 ↗At a glance
Multizentrische Studie in Catheterization and Cardiovascular Interventions, 2025. Written by Feng Xia and 11 co-authors. Institution: Department of Cardiology, Wuhan Asia General Hospital, Wuhan, China. Major MEDLINE topics: Transcatheter Aortic Valve Replacement, Aortic Valve Insufficiency, Heart Valve Prosthesis, Aortic Valve. Cited 3 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: This study was supported by the National Natural Science Foundation of China (No. NSFC 82270377), Fujian Science and Technology Innovation Joint Funding Projec….
Abstract (original language)
Background
Transcatheter aortic valve replacement (TAVR) for pure native aortic regurgitation (PNAR) remains challenging. While the noncoronary sinus pivot implantation (NCPI) strategy showed promise with VitaFlow valve, its efficacy with other valves needs validation.
Aims
This study aims to evaluate the real‐world efficacy of the TaurusElite valve in patients with PNAR and to assess the impact of the NCPI strategy on procedural outcomes.
Methods
This registry‐based analysis included 121 PNAR patients from the prospective CCA Database‐NTCVR who underwent transfemoral TAVR with TaurusElite valve at seven Chinese centers (April 2022 to October 2024). A core laboratory assessed procedural imaging to classify patients into NCPI ( n = 81) and non‐NCPI ( n = 37) groups. Outcomes were evaluated per VARC‐3 criteria.
Results
The TaurusElite valve demonstrated good effectiveness (overall device success 90.9%). NCPI strategy showed superior outcomes: higher success rate (98.8% vs. 81.1%, p < 0.001), no valve‐in‐valve implantation (0% vs. 16.2%, p < 0.001), and lower permanent pacemaker requirement (3.7% vs. 18.9%, p = 0.006). NCPI (OR:6.08, 95% CI: 3.27−28.68) independently predicted success.
Conclusions
The TaurusElite valve is an effective treatment for PNAR, and the NCPI strategy provides significant additional benefits in improving procedural success and reducing complications compared to conventional approaches.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, Wuhan Asia General Hospital, Wuhan, China.
- Department of Cardiology, Provincial Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
- National Clinical Research Center for Interventional Medicine, Shanghai, China.
- Department of Cardiology, Shanghai Chest Hospital Affiliated With Shanghai Jiao Tong University, Shanghai, China.
- Department of Cardiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
ORCID profiles: WenZhi Pan, DaXin Zhou, JunBo Ge
Funding
- This study was supported by the National Natural Science Foundation of China (No. NSFC 82270377), Fujian Science and Technology Innovation Joint Funding Projec…
Cite
APA
Xia, F., Chen, X., Weng, Z., Pan, X., Liu, J., Zhou, H., Wu, L., Guo, Y., Zhang, L., Pan, W., Zhou, D., & Ge, J. (2025). Noncoronary Sinus Pivot Implantation (NCPI) Strategy for Transcatheter Aortic Valve Replacement With Self‐Expanding Valve in Pure Native Aortic Regurgitation: A Multicenter, Registry Study From the CCA Database‐NTCVR. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70183
Vancouver
Xia F, Chen X, Weng Z, Pan X, Liu J, Zhou H, et al. Noncoronary Sinus Pivot Implantation (NCPI) Strategy for Transcatheter Aortic Valve Replacement With Self‐Expanding Valve in Pure Native Aortic Regurgitation: A Multicenter, Registry Study From the CCA Database‐NTCVR. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70183
BibTeX
@article{Xia2025,
author = {Xia, Feng and Chen, XinJing and Weng, ZiLong and Pan, Xin and Liu, JinJun and Zhou, Hao and Wu, LianPin and Guo, YanSong and Zhang, LongYan and Pan, WenZhi and Zhou, DaXin and Ge, JunBo},
title = {Noncoronary Sinus Pivot Implantation (NCPI) Strategy for Transcatheter Aortic Valve Replacement With Self‐Expanding Valve in Pure Native Aortic Regurgitation: A Multicenter, Registry Study From the CCA Database‐NTCVR},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70183}
}
EUVIMED